Amaris Fuentes

560 total citations
15 papers, 461 citations indexed

About

Amaris Fuentes is a scholar working on Cardiology and Cardiovascular Medicine, Emergency Medical Services and Geriatrics and Gerontology. According to data from OpenAlex, Amaris Fuentes has authored 15 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Emergency Medical Services and 4 papers in Geriatrics and Gerontology. Recurrent topics in Amaris Fuentes's work include Patient Safety and Medication Errors (4 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Amaris Fuentes is often cited by papers focused on Patient Safety and Medication Errors (4 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Atrial Fibrillation Management and Outcomes (2 papers). Amaris Fuentes collaborates with scholars based in United States and Spain. Amaris Fuentes's co-authors include Colleen L. Nehl, Peter Scully, Seunghyun Lee, Kathryn M. Mayer, Jason H. Hafner, Hongwei Liao, Howard Monsour, Thomas Kaleekal, Katherine K. Perez and L. E. Peterson and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Critical Care Medicine.

In The Last Decade

Amaris Fuentes

13 papers receiving 453 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amaris Fuentes United States	6	278	259	230	71	45	15	461
You Li United States	10	249 0.9×	114 0.4×	215 0.9×	50 0.7×	12 0.3×	27	597
Peter Scully United States	4	277 1.0×	259 1.0×	227 1.0×	71 1.0×	45 1.0×	4	427
Jiří Slabý Czechia	11	199 0.7×	79 0.3×	148 0.6×	19 0.3×	66 1.5×	22	415
Philip J. R. Roche Canada	13	272 1.0×	41 0.2×	136 0.6×	36 0.5×	70 1.6×	23	423
Tingzhuo Liu China	8	176 0.6×	252 1.0×	66 0.3×	189 2.7×	63 1.4×	18	394
Walker McHugh United States	8	329 1.2×	60 0.2×	279 1.2×	28 0.4×	58 1.3×	9	486
Zhongwen Li China	11	75 0.3×	65 0.3×	106 0.5×	186 2.6×	77 1.7×	36	468
Steven M. Asiala United States	8	179 0.6×	197 0.8×	117 0.5×	55 0.8×	17 0.4×	9	334
Pushpinder Kanda Canada	13	252 0.9×	39 0.2×	381 1.7×	41 0.6×	18 0.4×	23	561
Sang Hoon Kim South Korea	10	209 0.8×	26 0.1×	246 1.1×	34 0.5×	42 0.9×	18	462

Countries citing papers authored by Amaris Fuentes

Since Specialization

Citations

This map shows the geographic impact of Amaris Fuentes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amaris Fuentes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amaris Fuentes more than expected).

Fields of papers citing papers by Amaris Fuentes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amaris Fuentes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amaris Fuentes. The network helps show where Amaris Fuentes may publish in the future.

Co-authorship network of co-authors of Amaris Fuentes

This figure shows the co-authorship network connecting the top 25 collaborators of Amaris Fuentes. A scholar is included among the top collaborators of Amaris Fuentes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amaris Fuentes. Amaris Fuentes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Fuentes, Amaris, et al.. (2024). Impact of a patient risk–scoring tool pilot on prioritization of pharmacy-conducted medication histories. Journal of the American Pharmacists Association. 64(4). 102100–102100.

Fuentes, Amaris, et al.. (2023). Impact of a passive clinical decision support tool on potentially inappropriate medications ( PIM ) use in older adult patients. Journal of the American Geriatrics Society. 71(11). 3584–3594. 5 indexed citations

Fuentes, Amaris, et al.. (2022). Integration of Medication Safety Training and Development of a Culture of Safety in Pharmacy Education. SHILAP Revista de lepidopterología. 20–25. 1 indexed citations

Tran, Anh Thu, et al.. (2022). Alteplase for the treatment of midline catheter occlusions: a retrospective, single-cohort descriptive study. British Journal of Nursing. 31(14). S6–S16. 1 indexed citations

Fuentes, Amaris, et al.. (2021). Establishing a multidisciplinary taskforce to improve anticoagulation safety at a large health system. American Journal of Health-System Pharmacy. 79(4). 297–305.

Fuentes, Amaris, et al.. (2021). Analysis of Direct Oral Anticoagulant Therapy With Concomitant Use of Interacting Antiretroviral Agents. Journal of Pharmacy Practice. 36(2). 286–294. 2 indexed citations

Fuentes, Amaris, et al.. (2019). Evaluation of heparin induced thrombocytopenia using probability scores in a mechanical circulatory support population. Journal of Thrombosis and Thrombolysis. 48(1). 134–140. 7 indexed citations

Tuazon, Divina, et al.. (2019). Evaluation of Neuromuscular Blockade Reversal on Postoperative Mechanical Ventilation Time in a Cardiovascular Surgery Population. Journal of Cardiothoracic and Vascular Anesthesia. 33(12). 3348–3357. 1 indexed citations

Fuentes, Amaris, et al.. (2016). Postoperative antimicrobials after lung transplantation and the development of multidrug‐resistant bacterial and Clostridium difficile infections: an analysis of 500 non‐cystic fibrosis lung transplant patients. Clinical Transplantation. 30(7). 767–773. 12 indexed citations

10.

Fuentes, Amaris, et al.. (2014). Comparison of Anti-Xa and Activated Partial Thromboplastin Time Monitoring for Heparin Dosing in Patients With Cirrhosis. Therapeutic Drug Monitoring. 37(1). 40–44. 21 indexed citations

11.

Mudambi, Lakshmi, et al.. (2014). Belatacept as Primary Immunosuppression in a Lung Transplant Recipient. The Journal of Heart and Lung Transplantation. 33(4). S31–S31. 5 indexed citations

12.

Fuentes, Amaris, et al.. (2012). 907. Critical Care Medicine. 40. 1–328. 1 indexed citations

13.

Fuentes, Amaris, et al.. (2012). A new epoprostenol formulation for the treatment of pulmonary arterial hypertension. American Journal of Health-System Pharmacy. 69(16). 1389–1393. 12 indexed citations

14.

Mayer, Kathryn M., Seunghyun Lee, Hongwei Liao, et al.. (2008). A Label-Free Immunoassay Based Upon Localized Surface Plasmon Resonance of Gold Nanorods. ACS Nano. 2(4). 687–692. 384 indexed citations

15.

Fuentes, Amaris, et al.. (2001). [The effect of encephalogram bispectral index monitoring during total intravenous anesthesia with propofol in outpatient surgery].. PubMed. 48(6). 264–9. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact